Latest round: IPO. Sekar Kathiresan is a physician-scientist, human geneticist, Co-founder, and Chief Executive Officer of Verve Therapeutics.
Sekar Kathiresan is a physician-scientist, human geneticist, Co-founder, and Chief Executive Officer of Verve Therapeutics. The company is a clinical-stage biotechnology firm focused on developing gene editing medicines for cardiovascular disease. He leads efforts to create single-course gene editing treatments to permanently lower cholesterol.
Full founder directory · Investor directory · Company funding database · Fundraising library